- Home
- ETON vs PDYN Comparison
ETON vs PDYN Comparison
Compare ETON & PDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- PDYN
- Stock Information
- Founded
- ETON 2017
- PDYN 1983
- Country
- ETON United States
- PDYN United States
- Employees
- ETON N/A
- PDYN N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- PDYN Wholesale Distributors
- Sector
- ETON Health Care
- PDYN Industrials
- Exchange
- ETON Nasdaq
- PDYN Nasdaq
- Market Cap
- ETON 329.8M
- PDYN 271.2M
- IPO Year
- ETON 2018
- PDYN N/A
- Fundamental
- Price
- ETON $13.26
- PDYN $6.27
- Analyst Decision
- ETON Strong Buy
- PDYN
- Analyst Count
- ETON 3
- PDYN 0
- Target Price
- ETON $27.67
- PDYN N/A
- AVG Volume (30 Days)
- ETON 219.8K
- PDYN 1.4M
- Earning Date
- ETON 05-08-2025
- PDYN 05-07-2025
- Dividend Yield
- ETON N/A
- PDYN N/A
- EPS Growth
- ETON N/A
- PDYN N/A
- EPS
- ETON N/A
- PDYN N/A
- Revenue
- ETON $39,011,000.00
- PDYN $7,786,000.00
- Revenue This Year
- ETON $92.33
- PDYN N/A
- Revenue Next Year
- ETON $52.62
- PDYN $105.66
- P/E Ratio
- ETON N/A
- PDYN N/A
- Revenue Growth
- ETON 23.29
- PDYN 26.68
- 52 Week Low
- ETON $3.03
- PDYN $1.26
- 52 Week High
- ETON $18.41
- PDYN $14.95
- Technical
- Relative Strength Index (RSI)
- ETON 41.34
- PDYN 43.63
- Support Level
- ETON $12.24
- PDYN $5.56
- Resistance Level
- ETON $13.64
- PDYN $8.00
- Average True Range (ATR)
- ETON 0.95
- PDYN 0.65
- MACD
- ETON -0.14
- PDYN -0.09
- Stochastic Oscillator
- ETON 29.23
- PDYN 28.69
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About PDYN Palladyne AI Corp.
Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.